Acadia Healthcare Company (ACHC) Cost of Revenue (2010 - 2026)

Acadia Healthcare Company has disclosed Cost of Revenue across 17 years of filings, most recently posting $131.1 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 362.49% year-over-year to $131.1 million; the TTM figure through Mar 2026 stood at $326.7 million (up 14.12% YoY), while the FY2025 annual figure was $118.0 million, down 73.22% from the prior year.
• Cost of Revenue grew to $131.1 million in Q1 2026, from $30.8 million in the prior quarter.
• Over the last five years, Cost of Revenue for ACHC reached as high as $309.6 million in Q4 2023 and fell as low as $26.7 million in Q1 2024.
• The 5-year median for Cost of Revenue is $89.0 million (2022), against an average of $99.6 million.
• The widest YoY moves for Cost of Revenue: up 382.15% in 2025, down 73.91% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $275.0 million in 2022, then grew by 12.59% to $309.6 million in 2023, then plunged by 61.92% to $117.9 million in 2024, then sank by 73.91% to $30.8 million in 2025, then jumped by 326.12% to $131.1 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $131.1 million, $30.8 million, and $30.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.